• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏病学与生活方式医学。

Cardiology and lifestyle medicine.

机构信息

Division of Cardiology, Mount Sinai Morningside Hospital, Mount Sinai Heart, and the Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, United States of America.

出版信息

Prog Cardiovasc Dis. 2023 Mar-Apr;77:4-13. doi: 10.1016/j.pcad.2023.04.004. Epub 2023 Apr 12.

DOI:10.1016/j.pcad.2023.04.004
PMID:37059409
Abstract

Poor lifestyle habits, such as physical inactivity and poor diets, are highly prevalent within society and even more so among patients with chronic disease. The need to stem poor lifestyle habits has led to the development of a new field of Lifestyle Medicine, whose mission is to prevent, treat, and even reverse chronic diseases through lifestyle interventions. Three fields within Cardiology relate to this mission: Cardiac Rehabilitation, Preventive Cardiology, and Behavioral Cardiology. Each of these three fields have contributed substantially to the reduction of cardiovascular disease (CVD) morbidity and mortality. The historic contributions of these three cardiac fields are reviewed as well as the challenges each of these fields has faced in optimizing the application of lifestyle medicine practices. A shared agenda between Cardiology and the American College of Lifestyle Medicine could further the utilization of behavioral interventions. This review suggests seven steps that could be shared by these organizations and other medical societies. First, there is a need to develop and promulgate the assessment of lifestyle factors as "vital signs" during patient visits. Second, developing a strong partnership between the fields of Cardiology and Physiatry could improve important aspects of cardiac care, including a potential redesign of cardiac stress testing. Third, behavioral evaluations should be optimized at patients' entrée points into medical care since these may be considered "windows of opportunity". Fourth, there is a need to broaden cardiac rehabilitation into inexpensive programs and make this program eligible for patients with risk factors but no known CVD. Fifth, lifestyle medicine education should be integrated into the core competencies for relevant specialties. Sixth, there is a need for inter-societal advocacy to promote lifestyle medicine practices. Seventh, the well-being effects of healthy lifestyle behaviors, such as their impact on one's sense of vitality, should be emphasized.

摘要

不良的生活方式习惯,如缺乏身体活动和不良饮食,在社会中非常普遍,在慢性病患者中更是如此。遏制不良生活方式习惯的需求催生了一个新的领域——生活方式医学,其使命是通过生活方式干预来预防、治疗甚至逆转慢性病。心脏病学中有三个领域与这一使命相关:心脏康复、预防心脏病学和行为心脏病学。这三个领域都为降低心血管疾病(CVD)发病率和死亡率做出了巨大贡献。本文回顾了这三个心脏领域的历史贡献,以及每个领域在优化生活方式医学实践应用方面所面临的挑战。心脏病学和美国生活方式医学学院之间的共同议程可以进一步促进行为干预的应用。这篇综述提出了这两个组织和其他医学协会可以共享的七个步骤。首先,需要将生活方式因素的评估作为患者就诊时的“生命体征”进行开发和推广。其次,心脏病学和物理治疗学领域之间建立强有力的伙伴关系可以改善心脏护理的重要方面,包括对心脏压力测试的潜在重新设计。第三,应在患者进入医疗保健的入口点优化行为评估,因为这些可能被视为“机会之窗”。第四,需要将心脏康复扩展到低成本的项目,并使该项目适用于有风险因素但没有已知 CVD 的患者。第五,应将生活方式医学教育纳入相关专业的核心能力中。第六,需要倡导跨协会来促进生活方式医学实践。第七,应强调健康生活方式行为的健康效益,例如它们对活力感的影响。

相似文献

1
Cardiology and lifestyle medicine.心脏病学与生活方式医学。
Prog Cardiovasc Dis. 2023 Mar-Apr;77:4-13. doi: 10.1016/j.pcad.2023.04.004. Epub 2023 Apr 12.
2
Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology.心血管疾病患者临床管理中的二级预防。转诊与实施的核心要素、标准及结局指标:欧洲心血管预防与康复协会心脏康复分会的政策声明。经欧洲心脏病学会实践指南委员会认可。
Eur J Prev Cardiol. 2014 Jun;21(6):664-81. doi: 10.1177/2047487312449597. Epub 2012 Jun 20.
3
Nutrition and physical activity recommendations from the United States and European cardiovascular guidelines: a comparative review.美国和欧洲心血管指南中的营养和身体活动建议:比较综述。
Curr Opin Cardiol. 2020 Sep;35(5):508-516. doi: 10.1097/HCO.0000000000000763.
4
Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.家庭心脏康复:美国心血管和肺脏康复协会、美国心脏协会和美国心脏病学会的科学声明。
Circulation. 2019 Jul 2;140(1):e69-e89. doi: 10.1161/CIR.0000000000000663. Epub 2019 May 13.
5
[25 years of organized ambulatory heart sport in Luxembourg. The development of a sustained rehabilitation model].[卢森堡25年的有组织门诊心脏运动。一种持续康复模式的发展]
Bull Soc Sci Med Grand Duche Luxemb. 2011(1):7-17.
6
AACVPR/ACCF/AHA 2010 Update: Performance Measures on Cardiac Rehabilitation for Referral to Cardiac Rehabilitation/Secondary Prevention Services Endorsed by the American College of Chest Physicians, the American College of Sports Medicine, the American Physical Therapy Association, the Canadian Association of Cardiac Rehabilitation, the Clinical Exercise Physiology Association, the European Association for Cardiovascular Prevention and Rehabilitation, the Inter-American Heart Foundation, the National Association of Clinical Nurse Specialists, the Preventive Cardiovascular Nurses Association, and the Society of Thoracic Surgeons.美国心血管和肺康复协会/美国心脏病学会基金会/美国心脏协会2010年更新版:心脏康复转诊至心脏康复/二级预防服务的性能指标,获美国胸科医师学会、美国运动医学学会、美国物理治疗协会、加拿大心脏康复协会、临床运动生理学会、欧洲心血管预防与康复协会、泛美心脏基金会、全国临床护理专家协会、预防性心血管护士协会以及胸外科医师协会认可。
J Am Coll Cardiol. 2010 Sep 28;56(14):1159-67. doi: 10.1016/j.jacc.2010.06.006.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》(2012年版):欧洲心脏病学会及其他学会临床实践心血管疾病预防联合特别工作组(由九个学会的代表及特邀专家组成)。
Atherosclerosis. 2012 Jul;223(1):1-68. doi: 10.1016/j.atherosclerosis.2012.05.007. Epub 2012 May 14.
9
Healthy Lifestyle Interventions to Combat Noncommunicable Disease—A Novel Nonhierarchical Connectivity Model for Key Stakeholders: A Policy Statement From the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine.健康生活方式干预以防治非传染性疾病——关键利益攸关方的新型非层次连通性模型:美国心脏协会、欧洲心脏病学会、欧洲心血管预防与康复协会和美国预防医学学院的政策声明。
Mayo Clin Proc. 2015 Aug;90(8):1082-103. doi: 10.1016/j.mayocp.2015.05.001. Epub 2015 Jul 2.
10
2013 American Heart Association/American College of Cardiology Guideline on Lifestyle Management to Reduce Cardiovascular Risk: practice opportunities for registered dietitian nutritionists.2013年美国心脏协会/美国心脏病学会降低心血管风险生活方式管理指南:注册营养师的实践机会
J Acad Nutr Diet. 2014 Nov;114(11):1723-9. doi: 10.1016/j.jand.2014.07.037. Epub 2014 Oct 24.

引用本文的文献

1
Behavioural Cardiology: A Review on an Expanding Field of Cardiology-Holistic Approach.行为心脏病学:关于心脏病学不断扩展领域的综述——整体方法
J Pers Med. 2025 Aug 4;15(8):355. doi: 10.3390/jpm15080355.
2
Patient-Centered Risk Prediction, Prevention, and Intervention Platform (TIMELY) to Support the Continuum of Care in Coronary Artery Disease Using eHealth and Artificial Intelligence: Protocol for a Randomized Controlled Trial.以患者为中心的风险预测、预防和干预平台(TIMELY):利用电子健康和人工智能支持冠心病连续护理的随机对照试验方案
JMIR Res Protoc. 2025 Aug 14;14:e66283. doi: 10.2196/66283.
3
Endothelial Dysfunction in Acute Myocardial Infarction: A Complex Association With Sleep Health, Traditional Cardiovascular Risk Factors and Prognostic Markers.
急性心肌梗死中的内皮功能障碍:与睡眠健康、传统心血管危险因素及预后标志物的复杂关联
Clin Cardiol. 2025 Jan;48(1):e70080. doi: 10.1002/clc.70080.
4
Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy.抗消费剂:替尔泊肽和司美格鲁肽用于治疗肥胖相关疾病和成瘾,并提高预期寿命。
Prog Cardiovasc Dis. 2025 Mar-Apr;89:102-112. doi: 10.1016/j.pcad.2024.12.010. Epub 2024 Dec 30.
5
Adoption and perception of prescribable digital health applications (DiGA) and the advancing digitalization among German internal medicine physicians: a cross-sectional survey study.德国内科医生对可处方数字健康应用程序(DiGA)的采用和认知,以及不断推进的数字化:一项横断面调查研究。
BMC Health Serv Res. 2024 Nov 6;24(1):1353. doi: 10.1186/s12913-024-11807-1.
6
A comparative study on the physical fitness of college students from different grades and majors in Jiangxi province.江西省不同年级和专业大学生体质的比较研究。
PLoS One. 2024 Oct 16;19(10):e0308483. doi: 10.1371/journal.pone.0308483. eCollection 2024.
7
County-level socio-environmental factors and obesity prevalence in the United States.美国县级社会环境因素与肥胖流行状况。
Diabetes Obes Metab. 2024 May;26(5):1766-1774. doi: 10.1111/dom.15488. Epub 2024 Feb 14.